The Reserve Bank of India (RBI) maintained an accommodative stance and cut the real Gross Domestic Product (GDP) growth projection for the 2022-23 to 7.2 percent, against the earlier projection of 7.8 percent.
Expert panel of the Drug Controller General of India (DCGI) has recommended granting emergency use authorisation for Corbevax for children in the 5 to 12 years age group.